Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
Key Clinical Message In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID‐19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the vaccination. Abstract BBIBP‐CorV COVID‐19 vac...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-06-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7535 |
| _version_ | 1797791748929355776 |
|---|---|
| author | Ali Riazi Masood Faghih Dinevari Samaneh Abbasian Amirreza Jabbaripour Sarmadian |
| author_facet | Ali Riazi Masood Faghih Dinevari Samaneh Abbasian Amirreza Jabbaripour Sarmadian |
| author_sort | Ali Riazi |
| collection | DOAJ |
| description | Key Clinical Message In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID‐19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the vaccination. Abstract BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine) is an inactivated whole virus vaccine to control the COVID‐19 pandemic. Studies concluded that inactivated COVID‐19 vaccines do not increase the risk of thrombosis. This report presents a 23‐year‐old man with the chief complaint of severe pain, swelling, and erythema of the right upper extremity following his second dose of the Sinopharm vaccine. Duplex ultrasound of the right upper extremity revealed upper extremity deep vein thrombosis, and treatment started with oral anticoagulation. It is probably the first upper extremity deep vein thrombosis case following inactivated COVID‐19 vaccines. |
| first_indexed | 2024-03-13T02:23:10Z |
| format | Article |
| id | doaj.art-8992cd2df83f439e8e12344dac363a89 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-03-13T02:23:10Z |
| publishDate | 2023-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-8992cd2df83f439e8e12344dac363a892023-06-30T07:34:07ZengWileyClinical Case Reports2050-09042023-06-01116n/an/a10.1002/ccr3.7535Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case reportAli Riazi0Masood Faghih Dinevari1Samaneh Abbasian2Amirreza Jabbaripour Sarmadian3Liver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences Tabriz IranLiver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences Tabriz IranLiver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences Tabriz IranLiver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences Tabriz IranKey Clinical Message In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID‐19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the vaccination. Abstract BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine) is an inactivated whole virus vaccine to control the COVID‐19 pandemic. Studies concluded that inactivated COVID‐19 vaccines do not increase the risk of thrombosis. This report presents a 23‐year‐old man with the chief complaint of severe pain, swelling, and erythema of the right upper extremity following his second dose of the Sinopharm vaccine. Duplex ultrasound of the right upper extremity revealed upper extremity deep vein thrombosis, and treatment started with oral anticoagulation. It is probably the first upper extremity deep vein thrombosis case following inactivated COVID‐19 vaccines.https://doi.org/10.1002/ccr3.7535BIBP COVID‐19 vaccineCOVID‐19COVID‐19 vaccinesdeep vein thrombosis |
| spellingShingle | Ali Riazi Masood Faghih Dinevari Samaneh Abbasian Amirreza Jabbaripour Sarmadian Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report Clinical Case Reports BIBP COVID‐19 vaccine COVID‐19 COVID‐19 vaccines deep vein thrombosis |
| title | Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report |
| title_full | Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report |
| title_fullStr | Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report |
| title_full_unstemmed | Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report |
| title_short | Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report |
| title_sort | upper extremity deep vein thrombosis following bbibp corv covid 19 vaccine sinopharm vaccine a case report |
| topic | BIBP COVID‐19 vaccine COVID‐19 COVID‐19 vaccines deep vein thrombosis |
| url | https://doi.org/10.1002/ccr3.7535 |
| work_keys_str_mv | AT aliriazi upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport AT masoodfaghihdinevari upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport AT samanehabbasian upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport AT amirrezajabbaripoursarmadian upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport |